Results 161 to 170 of about 19,221 (177)

Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation. [PDF]

Int J Mol Sci
Terasaki M, Yashima H, Mori Y, Saito T, Inoue N, Matsui T, Osaka N, Fujikawa T, Ohara M, Yamagishi SI.   +9 more
europepmc   +1 more source

G protein-coupled receptors as new therapeutic targets for type 2 diabetes [PDF]

, 2015
Fiona M. Gribble, Frank Reimann
core   +1 more source

Skeletal Muscle Mass and Body Weight Fall Proportionally With Use of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Tirzepatide: Case Report and Review of Literature. [PDF]

AACE Clin Case Rep
Zinn J, Poretsky L.
europepmc   +1 more source

Gastrointestinal effects of extra-virgin olive oil associated with lower postprandial glycemia in type 1 diabetes [PDF]

, 2019
Alderisio, Antonio, Annuzzi, Giovanni, Barone, Francesca, Bozzetto, Lutgarda, Cipriano, Paola, Clemente, Gennaro, Costabile, Giuseppina, Giacco, Angela, Giorgini, Marisa, Griffo, Ettore, Riccardi, Gabriele, Rivellese, Angela Albarosa, Vetrani, Claudia   +12 more
core   +1 more source

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update. [PDF]

Endocrinol Metab (Seoul)
Jakubowska A, Roux CWL, Viljoen A.
europepmc   +1 more source

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. [PDF]

Addiction
Qeadan F, McCunn A, Tingey B.
europepmc   +1 more source

A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide. [PDF]

Cureus
Le TTB, Minh LHN, Devi P, Islam N, Sachmechi I.   +4 more
europepmc   +1 more source

Correction to: "Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease".

Endocr Rev
europepmc   +1 more source

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease. [PDF]

Med Princ Pract
Al-Sabah S, Al-Khairi I, Jamal M, Qaddoumi M, Alajmi F, Kumar J, Abukhalaf N, Cherian P, Madhu D, Arefanian H, Dsouza C, Alam-Eldin N, AlSabagh A, Al Madhoun A, Al-Sabah S, Al-Mulla F, Abu-Farha M, Abubaker J.   +17 more
europepmc   +1 more source

Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet.

Am J Physiol Endocrinol Metab
Lewandowski SL, El K, Campbell JE.
europepmc   +1 more source